PT-141 serves as a cutting-edge cyclic melanocortin agonist that demonstrates potential in the treatment of sexual dysfunction. This novel compound functions by enhancing specific receptors throughout the body, leading to improved sexual performance. Research studies have revealed that PT-141 may remarkably address a spectrum of sexual dysfunction